Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

pharmiweb.com today archive

3006 PWToday Stories

SK Life Science selects Patheon as development partner for CNS drug program

09 Jul 08


SK Life Science, the US-based subsidiary of Korean SK Holdings, has selected Patheon as their development services partner for two additional innovative central nervous system drug candidates.




Patheon will provide formulation and analytical development services as well as clinical supplies for one of the CNS candidates in multiple dosage forms for SK Life Science's advanced clinical studies.




In addition, Patheon will provide development and clinical materials manufacturing services for another CNS candidate in Phase I clinical trials.

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.